Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
30M
Number of holders
30
Total 13F shares, excl. options
4.04M
Shares change
-1.32M
Total reported value, excl. options
$2.46M
Value change
-$820K
Number of buys
10
Number of sells
-8
Price
$0.61

Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q4 2024

33 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q4 2024.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4.04M shares of 30M outstanding shares and own 13.47% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.73M shares), Kent Lake PR LLC (1M shares), VANGUARD GROUP INC (594K shares), Cresset Asset Management, LLC (300K shares), GEODE CAPITAL MANAGEMENT, LLC (164K shares), RENAISSANCE TECHNOLOGIES LLC (75.9K shares), BlackRock, Inc. (54.7K shares), Compagnie Lombard Odier SCmA (25K shares), NORTHERN TRUST CORP (24.9K shares), and STATE STREET CORP (23.2K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.